Hyperlipidemias: Clinical Trials

40 trials for Hyperlipidemias, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

40 unknown. 40 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 440Unknown 40

Follow Hyperlipidemias: new trials by email Literature Review of Hyperlipidemias trials Research Report on Hyperlipidemias

Trials (filtered) newest first · largest first

All 40 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Small Interfering RNA Inclisiran on Carotid Plaques As Assessed by Carotid Ultrasound
Inclisiran - Carotid Plaque, Hyperlipidemia
Phase 4UnknownFirst Affiliated Hospital of Xinjiang Medical University402024-09-202024-09-19
Study of the Efficacy and Safety of EPA in Patients With Type-2 Diabetes
EPAVasc, Corn Oil - Diabetes Type 2, Hypertriglyceridemia
Phase 4UnknownUniversity of Ioannina4502023-12-012023-11-15
Insulin and Standard Management in Hypertriglyceridemic Acute Pancreatitis
insulin, standard treatment - Hypertriglyceridemia, Acute Pancreatitis
Phase 4UnknownUniversity Medical Centre Ljubljana302022-11-012022-11-01
Compare the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy Versus Rosuvastatin Monotherapy in Korean Patients With Left Ventricular Diastolic Dysfunction and Hyperlipidemia
Rosuvastatin 20, Rosuvamibe 10/10 - Left Ventricular Diastolic Dysfunction, Hyperlipidemias
Phase 4UnknownYonsei University2002021-01-062021-01-15
Evolocumab Plus Ezetimibe in Haemodialized Statin-intolerant Patients With Hypercholesterolemia
Evolocumab, Ezetimibe, Placebo - Hypercholesterolemia, CKD Stage 5
Phase 4UnknownPoliclinico Casilino ASL RMB502020-11-012020-12-17
Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients
Evolocumab, Placebo, Ezetimibe - Hypercholesterolemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 4UnknownPoliclinico Casilino ASL RMB502020-05-042020-05-26
Effect of Atorvastatin on Carotid Intima Media Thickness
Perindopril/Amlodipine and Perindopril/Amlodipine/Atorvastatin treatment - Essential Hypertension, Hypercholesterolemia
Phase 4UnknownYerevan State Medical University2002020-04-152020-03-13
Effects of Evolocumab Versus Placebo Added to Standard Lipid-lowering Therapy on Fasting and Post Fat Load Lipids in Patients With Familial Dysbetalipoproteinemia
Evolocumab Auto-Injector [Repatha], Placebos - Familial Dysbetalipoproteinemia, Hyperlipoproteinemia Type III
Phase 4UnknownUMC Utrecht302019-08-012019-01-22
Lipid-lowering Therapies in Vietnamese Chronic Kidney Disease Population
Simvastatin 40mg, Ezetimibe/simvastatin 10/20 mg/day, Ezetimibe/simvastatin 10/40 mg/day - Hypercholesterolemia, Chronic Kidney Diseases
Phase 4UnknownHue University of Medicine and Pharmacy302018-06-152019-08-13
Pharmacokinetics of Simvastatin Post Laparoscopic Sleeve Gastrectomy (LSG)
Simvastatin - Obesity, Hyperlipidemias
Phase 4UnknownNational University Hospital, Singapore102018-06-132022-04-08
Intensive Insulin for Severe/Moderate Hypertriglyceridemia Pancreatitis.
Insulin, plasmapheresis - Acute Pancreatitis, Hypertriglyceridemia
Phase 4UnknownFirst Affiliated Hospital of Wenzhou Medical University2002018-06-062018-06-06
Effect of Evolocumab in Functional Status and LDL Oxidation of Patients With Peripheral Arterial Disease
Evolocumab 140 mg/mL Subcutaneous Injection 1 milliliter (mL) pre-filled injector Pen x 3 for a monthly dose of 420 mg for 6 months., Placebo 1milliliter (mL) Subcutaneous Injection pre-filled injector Pen x 3 monthly for 6 months. - Peripheral Arterial Disease
Phase 4UnknownLeonardo Clavijo862017-12-142020-03-12
Intravenous Administration of Insulin and Plasma Exchange on Triglyceride Levels in Early Stage of Hypertriglyceridemia-induced Pancreatitis
Insulin, Aphesis - Pancreatitis, Acute, Hypertriglyceridemia
Phase 4UnknownPeking Union Medical College Hospital2202017-11-012017-11-17
Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab
Alirocumab - Atherosclerosis, Hyperlipidemia
Phase 4UnknownWestside Medical Associates of Los Angeles352016-11-012019-04-26
Effect of Rosuvastatin Therapy on HDL2 Level
Rosuvastatin 10mg/d group, Rosuvastatin 20mg/d group - Hyperlipemia, Coronary Heart Disease
Phase 4UnknownDaping Hospital and the Research Institute of Surgery of the Third Military Medical University3002015-11-012015-11-03
Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI
Rosuvastatin 5mg, Rosuvastatin 20mg - Coronary Artery Disease, Coronary Disease
Phase 4UnknownKorea University Anam Hospital3002015-09-012016-08-09
Nutraceuticals to Improve Lipid Profile in European Countries
Non-pharmacologic intervention, Nutraceuticals (Armolipid Plus) - Hyperlipidemia
Phase 4UnknownUniversity of Roma La Sapienza1002014-01-012013-03-07
Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome
Fenofibrate, Simvastatin - Acute Coronary Syndrome, Diabetes Mellitus, Type 2
Phase 4UnknownKoval' O., MD602014-01-012016-08-04
Probiotic BIO-25 as a Supplement to Statins for the Treatment of Hypercholesterolemia
Food supplement - Hypercholesterolemia
Phase 4UnknownMeir Medical Center602013-05-012013-05-08
Lovaza Mechanisms of Action
Omega 3 fatty acid (Lovaza) - Moderate Hypertriglyceridemia.
Phase 4UnknownBrigham and Women's Hospital402012-08-012013-02-25

Showing 20 of 40. Sign in to see all of them.

Narrower conditions

Hypercholesterolemia (17)  ·  Hypertriglyceridemia (9)  ·  Diabetes Mellitus (6)  ·  Coronary Artery Disease (5)  ·  Atherosclerosis (4)  ·  Coronary Disease (4)  ·  Diabetes Mellitus, Type 2 (4)  ·  Hypertension (4)  ·  Inflammation (3)  ·  Pancreatitis (3)  ·  Renal Insufficiency, Chronic (3)  ·  Cardiovascular Diseases (2)  ·  Dyslipidemias (2)  ·  HIV Infections (2)

Broader conditions

Lipid Metabolism Disorders (40)  ·  Metabolic Diseases (40)  ·  Nutritional and Metabolic Diseases (40)  ·  Dyslipidemias (38)  ·  Vascular Diseases (15)  ·  Cardiovascular Diseases (14)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Glucose Metabolism Disorders (10)  ·  Arterial Occlusive Diseases (9)  ·  Arteriosclerosis (9)  ·  Endocrine System Diseases (8)  ·  Pathologic Processes (8)  ·  Urogenital Diseases (8)  ·  Heart Diseases (7)

Interventions

Rosuvastatin Calcium (8)  ·  Ezetimibe (5)  ·  Simvastatin (5)  ·  evolocumab (4)  ·  Atorvastatin (3)  ·  Fenofibrate (3)  ·  Insulin (3)  ·  Omacor (3)  ·  Dietary Supplements (2)  ·  Exercise (2)  ·  Population Groups (2)  ·  Pravastatin (2)  ·  ALN-PCS (1)  ·  Amlodipine (1)  ·  Aspirin (1)

Sponsors

Policlinico Casilino ASL RMB (2)  ·  University of Roma La Sapienza (2)  ·  Abant Izzet Baysal University (1)  ·  Azienda Ospedaliero Universitaria di Sassari (1)  ·  Brigham and Women's Hospital (1)  ·  Bronx VA Medical Center (1)  ·  Chinese PLA General Hospital (1)  ·  Danish HIV Research Group (1)  ·  Daping Hospital and the Research Institute of Surgery of the Third Military Medical University (1)  ·  First Affiliated Hospital of Wenzhou Medical University (1)  ·  First Affiliated Hospital of Xinjiang Medical University (1)  ·  Hanmi Pharmaceutical Company Limited (1)  ·  Hospital Universitario Pedro Ernesto (1)  ·  Hospital de Sabadell (1)  ·  Hue University of Medicine and Pharmacy (1)

Countries

Italy (8)  ·  United States (6)  ·  South Korea (5)  ·  China (3)  ·  Japan (3)  ·  Brazil (1)  ·  Denmark (1)  ·  Greece (1)  ·  Israel (1)  ·  Singapore (1)  ·  Spain (1)  ·  Turkey (Türkiye) (1)  ·  Ukraine (1)  ·  Vietnam (1)

Top investigators

Alex Laursen, M.D., DMSc (1)  ·  Andrea E Satta, MD (1)  ·  Angelo Branzi, MD (1)  ·  Ann-Brit E Hansen, M.D. (1)  ·  Asim Shabbir, MBBS (1)  ·  Charles Glueck, MD (1)  ·  Court Pedersen, Professor (1)  ·  Dario Giugliano, MD,PhD (1)  ·  Do-sun Lim, MD, PhD (1)  ·  Duong Thi Ngoc Lan, Master (1)  ·  Fernanda J Medeiros, PhD (1)  ·  Francesco Pelliccia, MD (1)  ·  Frank LJ Visseren, prof (1)  ·  Hamayak Sisakian, MD (1)

Results publications

PMID 38018702, PMID 17898099, PMID 18955731, PMID 22584085, PMID 22615342, PMID 23428644, PMID 24465490, PMID 24528685, PMID 24595147, PMID 24739590, PMID 24843697, PMID 25022285, PMID 25401325, PMID 27165949, PMID 28399815, PMID 28755807, PMID 30565155, PMID 31215460